ICMI 2015

Presidential Session

Thursday, July 16, 2015: 5:00 PM-6:30 PM
Hall Maritim, Ground Floor (Maritim Hotel)
Chair:
Kenneth Beagley, PhD
5:00 PM
Integrin αvβ8-Mediated TGFβ Activation by Effector Regulatory T-cells is Essential for Suppression of T-cell-Mediated Intestinal Inflammation
Mark Travis, University of Manchester; John Worthington, PhD, University of Manchester; Julien Marie, PhD, Cancer Research Center of Lyon C R C L; David Bauché, PhD, Cancer Research Center of Lyon C R C L; Catherine Smedley, University of Manchester; Aoife Kelly, PhD, University of Manchester; Simon Campbell, MD, Central Manchester University Hospital NHS Foundation Trust
5:20 PM
Targeting the Host to Reverse Infection-induced Immune Suppression Affords a Novel Approach to Therapy and Vaccine Development against Neisseria gonorrhoeae
Yingru Liu, MD, PhD, TherapyX, Inc.; Tara Phillips, TherapyX, Inc.; Laura Hammer, TherapyX, Inc.; Nejat Egilmez, PhD, University of Louisville; Michael Russell, PhD, University at Buffalo
6:00 PM
Type I Interferons Produced by Alveolar Macrophages are Important Drivers of Lung Inflammation During Respiratory Syncytial Virus (RSV) Infection
Michelle Goritzka, Imperial College London; Spyridon Makris, Imperial College London; Fahima Kausar, Imperial College London; Shizou Akira, Prof, Osaka University; Cecilia Johansson, Imperial College London
6:20 PM
Role of RIPK2 in protecting the intestinal epithelium from Caspase-8 mediated apoptosis
Dominique Bozec, Icahn School of Medicine at Mount Sinai; Stephanie Dahan, Mount Sinai Medical School; Garabet Yeretssian, Icahn School of Medicine at Mount Sinai
See more of: Plenary